House compounding bill differs from Senate version

06/18/2013 | FDALawBlog.net

A draft bill being circulated for comment in the House does not define a "compounding pharmacy" or create a special category for drug compounders as a Senate bill does but instead clarifies how the FDA should tell drug compounders apart from drug manufacturers.

View Full Article in:

FDALawBlog.net